España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Aerovate Therapeutics
AVTE
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.66
0.05
1.92%
At close: -
$2.66
0
0.00%
After Hours: Nov 22, 4:00 PM EDT
Get Report
Comment
Aerovate Therapeutics (AVTE) Forecast
News
Earnings
Aerovate Therapeutics (AVTE) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Aerovate Therapeutics (NASDAQ:AVTE) Stock
Aerovate Therapeutics Stock (NASDAQ: AVTE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, October 31, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Aerovate Therapeutics shares are trading high...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Aerovate Therapeutics And Privately-held Jade...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, October 01, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, July 08, 2024
Aerovate Therapeutics shares are trading high...
Benzinga Newsdesk
Aerovate Therapeutics To Explore Strategic Al...
Benzinga Newsdesk
Friday, June 21, 2024
Watching Aerovate Therapeutics; Shares Moving...
Benzinga Newsdesk
Tuesday, June 18, 2024
Evercore ISI Group Downgrades Aerovate Therap...
Benzinga Newsdesk
Guggenheim Downgrades Aerovate Therapeutics t...
Benzinga Newsdesk
Wells Fargo Downgrades Aerovate Therapeutics ...
Benzinga Newsdesk
Aerovate Therapeutics shares are trading lowe...
Benzinga Newsdesk
TD Cowen Downgrades Aerovate Therapeutics to ...
Benzinga Newsdesk
Monday, June 17, 2024
Nasdaq Surges Over 200 Points; Aaron's Shares Jump
Avi Kapoor
Jefferies Downgrades Aerovate Therapeutics to...
Benzinga Newsdesk
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
BTIG Downgrades Aerovate Therapeutics to Neut...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Crude Oil Rises 1%; Mustang Bio Shares Spike Higher
Avi Kapoor
Aerovate Therapeutics shares are trading lowe...
Benzinga Newsdesk
Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?
Vandana Singh
US Stocks Mixed; Dow Tumbles Over 100 Points
Avi Kapoor
Aerovate Therapeutics Announces 24-Week Topli...
Benzinga Newsdesk
Trading Halt: Halted at 8:25:00 a.m. ET - Tra...
Benzinga Newsdesk
Thursday, June 06, 2024
Wedbush Reiterates Outperform on Aerovate The...
Benzinga Newsdesk
Wednesday, May 22, 2024
Wedbush Reiterates Outperform on Aerovate The...
Benzinga Newsdesk
Tuesday, May 21, 2024
Aerovate Therapeutics Presents Baseline Data ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Wedbush Reiterates Outperform on Aerovate The...
Benzinga Newsdesk
Monday, May 13, 2024
Aerovate Therapeutics Q1 2024 GAAP EPS $(0.83...
Benzinga Newsdesk
Friday, April 05, 2024
Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday
Avi Kapoor
Monday, April 01, 2024
Wells Fargo Maintains Overweight on Aerovate ...
Benzinga Newsdesk
Wednesday, March 27, 2024
Aerovate Therapeutics To Present Patient Base...
Benzinga Newsdesk
Monday, March 25, 2024
Recap: Aerovate Therapeutics Q4 Earnings
Benzinga Insights
Aerovate Therapeutics Expects Cash, Cash Equi...
Benzinga Newsdesk
Aerovate Therapeutics Q4 2023 GAAP EPS $(0.74...
Benzinga Newsdesk
Jefferies Assumes Aerovate Therapeutics at Bu...
Benzinga Newsdesk
Wednesday, March 06, 2024
Aerovate Therapeutics Board Of Directors Appo...
Benzinga Newsdesk
Monday, November 20, 2023
Aerovate Reports Simultaneous Completion Of E...
Benzinga Newsdesk
Monday, November 13, 2023
Aerovate Therapeutics Q3 EPS $(0.71) Misses $...
Benzinga Newsdesk
Recap: Aerovate Therapeutics Q3 Earnings
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, September 11, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 14, 2023
Aerovate Therapeutics Q2 EPS $(0.76) Misses $(0.70) Estimate
Happy Mohamed
Friday, June 09, 2023
Aerovate Therapeutics Director Awarded $206K Worth of Stock Options
Benzinga Insights
Monday, May 22, 2023
Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data In Support Of AV-101, A Novel Dry Powder Inhaled Formulation Of Imatinib, At The American Thoracic Society 2023 International Conference
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch